Eventide Asset Management, LLC Eiger Bio Pharmaceuticals, Inc. Transaction History

Eventide Asset Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Nov 14, 2018	SELL	$9.6 - $12.9 $345,600 - $464,400	-36,000 Closed	0 $0
Q2 2018 Aug 14, 2018	SELL	$8.3 - $16.8 $224,100 - $453,600	-27,000 Reduced 42.86%	36,000 $439,000
Q1 2018 May 15, 2018	SELL	$8.1 - $16.0 $502,200 - $992,000	-62,000 Reduced 49.6%	63,000 $621,000
Q4 2017 Feb 14, 2018	BUY	$10.5 - $14.15 $1.31 Million - $1.77 Million	125,000	125,000 $1.74 Million

748K

Ticker EIGR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,966,800
Market Cap $496M
Description
Eiger BioPharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of targeted therapies for rare and ultra-rare diseases in the United States and internationally. Its lead product candidate is Lonafarnib, an orally bioavailable, small molecule, which is in Phase III clinical trials to ...

Get notified when there are updates to the investment portfolio of Eventide Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Eventide Asset Management, LLC with notifications on news.